Bin Zhou

Bin Zhou, PhD is an Assistant Professor of Immunochemistry in the Department of Chemistry. His research focuses on developing vaccines targeting psychoactive substances and drugs of abuse, including fentanyl analogs, heroin, and nicotine. He holds a B.S. in Biochemistry from Shanghai University of Science & Technology (1990) and a Ph.D. in Molecular Biology from Shanghai Research Center (1999).

His work emphasizes translational applications of immunological approaches to address addiction and overdose crises. Key research areas include vaccine design against opioids, monoclonal antibody therapies for nicotine addiction, and fluorescent probes for oncology drug discovery. Collaborations with institutions like the Janda lab highlight his commitment to bridging basic science and clinical applications.

Notable contributions include:

• Development of a benzimidazole-derived vaccine more potent than fentanyl
• Anti-nicotine monoclonal antibodies to mitigate nicotine effects
• Synthetic MYC probe for cancer drug screening

No academic awards or grants are explicitly mentioned in the provided materials. His current position does not indicate part-time status.